Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver T Stirrup

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of the International AIDS Society|May 22, 2021
Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trialDavid V Glidden, Moupali Das, David T Dunn, et al.
AIDS Research and Therapy|April 18, 2018
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK dataOliver T Stirrup, David T Dunn, Anna Tostevin, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of the International AIDS Society|May 22, 2021
Using the adherence-efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trialDavid V Glidden, Moupali Das, David T Dunn, et al.
AIDS Research and Therapy|April 18, 2018
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK dataOliver T Stirrup, David T Dunn, Anna Tostevin, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Pageof 2